Global Journal of Biology, Agriculture & Health Sciences

Mental Health and Epidemiology: Addressing the Global Burden of Mental Illness

Anne Helene Monsoro-Burq^* Department of Microbiology, Acibadem University, Istanbul, Turkey
^*Correspondence: Anne Helene Monsoro-Burq, Department of Microbiology, Acibadem University, Istanbul, Turkey, Email:

Received: 08-Feb-2023, Manuscript No. GJBAHS-23-19836; Editor assigned: 10-Feb-2023, Pre QC No. GJBAHS-23-19836(PQ); Reviewed: 24-Feb-2023, QC No. GJBAHS-23-19836; Revised: 10-May-2023, Manuscript No. GJBAHS-23-19836(R); Published: 17-May-2023, DOI: 10.35248/2319-5584.23.12.186

Introduction

Mental health refers to the psychological and emotional wellbeing of individuals, while epidemiology is the study of the distribution and determinants of health and disease in populations. Both fields work together to understand and address the impact of mental illness on individuals, families, and communities [1].

The global burden of mental illness is a growing concern for many countries. According to the World Health Organization (WHO), one in four people globally will be affected by mental or neurological disorders at some point in their lives [2]. This represents a significant burden on individuals, families, and societies, both in terms of the impact on daily life and the economic cost of treatment and support.

The impact of mental illness on daily life can be significant, with individuals experiencing a range of symptoms including depression, anxiety, and psychosis. These symptoms can affect daily functioning, including work and social activities, and can lead to decreased quality of life and increased risk of disability [3]. The impact on families can be just as significant, with caregiver’s often providing support and care for individuals with mental illness.

Epidemiology plays an important role in understanding the distribution of mental illness and the risk factors associated with its development. By studying patterns of mental illness in populations, epidemiology helps to identify the most vulnerable populations and to develop effective interventions to prevent and treat mental illness. This is important because mental illness is not equally distributed across populations, and some populations are at higher risk than others.

Description

One of the key risk factors for mental illness is poverty. People living in poverty are at increased risk of mental illness due to a range of factors, including poor living conditions, lack of access to healthcare and support services, and exposure to trauma and violence [4]. Moreover, individuals who experience poverty and social exclusion are more likely to engage in behaviors that increase the risk of mental illness, such as substance abuse and risky sexual behavior.

Another important factor that affects the distribution of mental illness is gender. Women are more likely to experience depression, anxiety, and other mental illnesses, while men are more likely to experience substance abuse and other behavioral problems. This disparity is likely due to a range of social, cultural, and biological factors, including differences in gender roles and exposure to trauma and stress [5].

The impact of mental illness on communities can be significant, with the cost of treatment and support often placing a burden on health systems and economies. In many countries, mental health services are underfunded and under resourced, with individuals with mental illness often receiving inadequate care and support. This can lead to increased risk of disability and reduced quality of life, as well as increased healthcare costs and decreased productivity [6].

To address the global burden of mental illness, it is important that governments and organizations work together to prioritize mental health and provide adequate resources and support. This includes investing in mental health research, improving access to mental health services, and addressing the social and economic factors that contribute to mental illness.

Conclusion

One of the ways to improve access to mental health services is through the integration of mental health into primary healthcare. This can include providing mental health screening and treatment in primary care settings, as well as ensuring that healthcare providers have the skills and knowledge to recognize and manage mental illness. This can help to reduce stigma and increase access to care for individuals with mental illness, particularly those who are more vulnerable and may not otherwise seek out mental health services.

Another important step in addressing the global burden of mental illness is to address the social and economic factors that contribute to its development. This includes investing in poverty reduction and social protection programs, improving access to education and employment opportunities, and addressing gender-based violence and discrimination.

References

1. Zhou D, Liu Y. Renal fibrosis in 2015: Understanding the mechanisms of kidney fibrosis. Nat Rev Nephrol. 2016;12(2):68-70.

   [Crossref] [Google Scholar] [PubMed]

2. Sun YB, Qu X, Caruana G, Li J. The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis. Differentiation. 2016;92(3):102-107.

   [Crossref] [Google Scholar] [PubMed]

3. Grass DG, Tool BP. How, with whom and when: An overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity. Biosci Rep. 2016; 36(1):e00283.

   [Crossref] [Google Scholar] [PubMed]

4. Kato N, Yuzawa Y, Kosugi T, Hobo A, Sato W, Miwa Y, et al. The E-selectin ligand basigin/CD147 is responsible for neutrophil recruitment in renal ischemia/reperfusion. J Am Soc Nephrol. 2009;20(7):1565-1576.

   [Crossref] [Google Scholar] [PubMed]

5. Seizer P, Ochmann C, Schonberger T, Zach S, Rose M, Borst O, et al. Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion. Arterioscler Thromb Vasc Biol. 2011;31(6):1377-1386.

   [Crossref] [Google Scholar] [PubMed]

6. Kosugi T, Maeda K, Sato W, Maruyama S, Kadomatsu K. CD147 (EMMPRIN/Basigin) in kidney diseases: From an inflammation and immune system viewpoint. Nephrol Dial Transplant. 2015;30(7):1097-1103.

   [Crossref] [Google Scholar] [PubMed]